GREY:ATTBF - Post by User
Post by
fasttrack5on Jul 13, 2018 2:41am
163 Views
Post# 28310605
H.J. On ignore
H.J. On ignoreThe article speaks for it self
Haul go ride your pony elsewhere Emerald Health Therapeutics (TSXV: EMH) gave an update on its different strategy and progress. Emerald heath which is currently trading at 1/3 of its 52 week high and half the price of their last 2 raises explained its 3 pillar business plan. Emh who currently holds a cultivation licence for their, Village farm partnered, 1.1m sq foot facility explained that Product Innovation, Branding & Sales, and Production and Raw Material Sourcing are their key strategies for future profitability. They also mentioned that their 53% owned Northern Vine Labs (which Abattis Bioceuticals Corp (CSE: ATT) owns the other 47%) who has a Dealers Licence is key in helping EMH research new products and import and export dried cannabis internationally. Hopefully, in the near future, Northern Vine Labs will help provide revenue for Abattis and EMH, which will then see a much-needed increase in share prices for both companies. Just like Huge with their 75k sq foot Quebec indoor facility once fully expanded they will have over 1.5m sq feet of growing space.